Thomas Malley Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas Malley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas Malley. Thomas Malley is Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in Cougar Biotechnology, Inc. ($CGRB) and Director in Kura Oncology, Inc. ($KURA) and Director in OvaScience, Inc. ($OVAS) and Director in BeiGene, Ltd. ($BGNE) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA).
Latest Insider Trading Transactions of Thomas Malley
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BGNE, CGRB, KNSA, KURA, OVAS, GEVA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 21.54 | 23,000 | 495,420 | 23,000 | |
Jul 02 2020 | KNSA | Kiniksa Pharmaceut ... | Malley Thomas | Director | Option Exercise | A | 25.48 | 18,760 | 478,005 | 18,760 | |
Jun 26 2020 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 17.97 | 23,000 | 413,310 | 23,000 | |
Jun 19 2020 | BGNE | BeiGene, Ltd. | Malley Thomas | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
Jun 27 2019 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 19.55 | 13,000 | 254,150 | 13,000 | |
Jun 07 2019 | BGNE | BeiGene, Ltd. | Malley Thomas | Director | Option Exercise | A | 9.23 | 64,610 | 596,350 | 64,610 | |
May 30 2019 | KNSA | Kiniksa Pharmaceut ... | Malley Thomas | Director | Option Exercise | A | 15.47 | 18,760 | 290,217 | 18,760 | |
Jun 08 2018 | BGNE | BeiGene, Ltd. | Malley Thomas | Director | Option Exercise | A | 16.15 | 17,442 | 281,688 | 17,442 | |
Jun 08 2018 | BGNE | BeiGene, Ltd. | Malley Thomas | Director | Grant | A | 0.00 | 9,290 | 0 | 9,290 | 0 to 9.3 K |
Jun 08 2018 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 16.35 | 13,000 | 212,550 | 13,000 | |
May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Malley Thomas | Director | Option Exercise | C | 0.00 | 71,967 | 0 | 0 | |
May 29 2018 | KNSA | Kiniksa Pharmaceut ... | Malley Thomas | Director | Buy | C | 0.00 | 71,967 | 0 | 71,967 | 0 to 72 K |
Jul 05 2017 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 7,873 | 0 | 204,981 | 197.1 K to 205 K (+3.99 %) |
Jun 12 2017 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 8.60 | 10,000 | 86,000 | 10,000 | |
Jun 06 2017 | BGNE | BeiGene, Ltd. | Malley Thomas | Director | Option Exercise | A | 3.16 | 169,988 | 537,162 | 169,988 | |
Apr 04 2017 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 7,085 | 0 | 197,108 | 190 K to 197.1 K (+3.73 %) |
Jan 04 2017 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 1.53 | 8,660 | 13,250 | 190,023 | 181.4 K to 190 K (+4.77 %) |
Nov 28 2016 | BGNE | BeiGene, Ltd. | Malley Thomas | Director | Buy | P | 32.00 | 30,000 | 960,000 | 30,000 | 0 to 30 K |
Oct 04 2016 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 1,850 | 0 | 181,363 | 179.5 K to 181.4 K (+1.03 %) |
Jul 05 2016 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 2,543 | 0 | 179,513 | 177 K to 179.5 K (+1.44 %) |
Jun 06 2016 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Option Exercise | A | 7.38 | 12,000 | 88,560 | 12,000 | |
Jun 03 2016 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 7.00 | 50,000 | 350,000 | 176,970 | 127 K to 177 K (+39.38 %) |
May 13 2016 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 3.12 | 10,000 | 31,200 | 10,000 | |
Apr 04 2016 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 1,396 | 0 | 126,970 | 125.6 K to 127 K (+1.11 %) |
Jan 05 2016 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 1,356 | 0 | 125,574 | 124.2 K to 125.6 K (+1.09 %) |
Dec 17 2015 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Buy | P | 8.00 | 50,000 | 400,000 | 89,557 | 39.6 K to 89.6 K (+126.40 %) |
Oct 14 2015 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 14.00 | 30,000 | 420,000 | 30,000 | |
Oct 02 2015 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 1,560 | 0 | 124,218 | 122.7 K to 124.2 K (+1.27 %) |
Jul 02 2015 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 28.93 | 458 | 13,250 | 122,658 | 122.2 K to 122.7 K (+0.37 %) |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 80.35 | 7,500 | 602,625 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 40.74 | 7,500 | 305,550 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 40.32 | 7,500 | 302,400 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 23.00 | 15,000 | 345,000 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 3.52 | 51 | 180 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 0.95 | 2,149 | 2,042 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Option Exercise | D | 0.95 | 5,226 | 4,965 | 0 | |
Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Director | Sell | D | 0.00 | 46,901 | 0 | 0 | 46.9 K to 0 (-100.00 %) |
Jun 08 2015 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Option Exercise | A | 36.19 | 12,000 | 434,280 | 12,000 | |
Apr 09 2015 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Buy | P | 28.50 | 5,000 | 142,500 | 122,200 | 117.2 K to 122.2 K (+4.27 %) |
Apr 02 2015 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 34.73 | 381 | 13,232 | 117,200 | 116.8 K to 117.2 K (+0.33 %) |
Jul 07 2009 | CGRB | Cougar Biotechnolo ... | Malley Thomas | Director | Option Exercise | D | 28.26 | 10,000 | 282,600 | 0 | |
Jul 07 2009 | CGRB | Cougar Biotechnolo ... | Malley Thomas | Director | Option Exercise | D | 24.05 | 30,000 | 721,500 | 0 | |
Jul 07 2009 | CGRB | Cougar Biotechnolo ... | Malley Thomas | Director | Sell | U | 43.00 | 19,918 | 856,474 | 0 | 19.9 K to 0 (-100.00 %) |
Jun 19 2008 | CGRB | Cougar Biotechnolo ... | Malley Thomas | Director | Option Exercise | A | 28.26 | 10,000 | 282,600 | 10,000 | |
Jul 20 2007 | CGRB | Cougar Biotechnolo ... | Malley Thomas | Director | Buy | P | 21.75 | 8,068 | 175,479 | 19,918 | 11.9 K to 19.9 K (+68.08 %) |
Jul 20 2007 | CGRB | Cougar Biotechnolo ... | Malley Thomas | Director | Buy | P | 21.75 | 8,500 | 184,875 | 11,850 | 3.4 K to 11.9 K (+253.73 %) |
Jul 20 2007 | CGRB | Cougar Biotechnolo ... | Malley Thomas | Director | Buy | P | 21.75 | 3,350 | 72,863 | 3,350 | 0 to 3.4 K |
Jun 15 2007 | CGRB | Cougar Biotechnolo ... | Malley Thomas | Director | Option Exercise | A | 24.05 | 30,000 | 721,500 | 30,000 |
Page: 1